Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
NCT07077473 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2026-01-27
Summary
retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world
Conditions
- Familial Mediterranean Fever (FMF )
Interventions
- DRUG
-
real word drugs
real word drugs
Sponsors & Collaborators
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
collaborator OTHER - collaborator INDUSTRY
- collaborator OTHER
-
Tongji Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir
NCT05108051 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts
NCT05415241 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
NCT04590222 ·Status: COMPLETED
-
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
NCT04532931 ·Status: COMPLETED ·Phase: PHASE2
-
Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.
NCT03212716 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Medications COVID-19
NCT05596617 ·Status: COMPLETED ·Phase: NA
-
Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial
NCT05946551 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection
NCT04766931 ·Status: COMPLETED ·Phase: PHASE1
-
Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)
NCT04565392 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
NCT05506176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.
NCT03679143 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
NCT01202279 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics,Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A
NCT06656026 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Early Antiviral Therapy on Duration of Cough in Flu Patients
NCT03618407 ·Status: UNKNOWN
-
A Study of VIS410 to Assess Safety and Pharmacokinetics
NCT02045472 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A
NCT04024137 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
NCT04779047 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older
NCT04798027 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of HS-10517 in Chinese Adult Participants
NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19
NCT04918927 ·Status: COMPLETED ·Phase: PHASE2
-
Adverse Effects of Ivermectin Used in Egypt During COVID-19
NCT04747678 ·Status: UNKNOWN
-
A Simple Approach to Treat COVID-19 Patients at Home.
NCT04794998 ·Status: COMPLETED
-
Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males
NCT01428479 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS
NCT04119440 ·Status: COMPLETED ·Phase: PHASE1